Indefinite Delivery Contract SPE2DX16D3922

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. This single-award IDC serves as the primary vehicle for Amerisourcebergen to efficiently provide these essential pharmaceutical and medical supplies to the DLA, which is the contracting agency for this award. The contract has an ultimate completion date of November 23, 2023 and was initially awarded on March 22, 2016.

Additionally, Amerisourcebergen's parent company, Cencora, Inc., holds a separate Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025. This larger IDC serves as another primary mechanism for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's global healthcare programs. Both of these IDCs demonstrate the companies' capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.